Evidence map›Paper›PMID 33469977›Full record

ArticleAngewandte Chemie (International ed. in English)2021

Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS-CoV-2 Spike Protein*.

Deborah K Shoemark, Charlotte K Colenso, Christine Toelzer, Kapil Gupta, Richard B Sessions, Andrew D Davidson, Imre Berger, Christiane Schaffitzel, James Spencer, Adrian J Mulholland

Open access · bronzeAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The Bidirectional Association Between Metabolic Syndrome and Long-COVID-19.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Deborah K ShoemarkSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK.ORCID 0000-0002-1240-8463
Charlotte K ColensoSchool of Cellular and Molecular Medicine, Biomedical Sciences Building, University of Bristol, Bristol, BS8 1TD, UK.ORCID 0000-0003-4125-4691
Christine ToelzerSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK.ORCID 0000-0001-9984-5940
Kapil GuptaSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK.
Richard B SessionsSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK.ORCID 0000-0003-0320-0895
Andrew D DavidsonSchool of Cellular and Molecular Medicine, Biomedical Sciences Building, University of Bristol, Bristol, BS8 1TD, UK.ORCID 0000-0002-1136-4008
Imre BergerSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK.ORCID 0000-0001-7518-9045
Christiane SchaffitzelSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK.ORCID 0000-0002-1516-9760
James SpencerSchool of Cellular and Molecular Medicine, Biomedical Sciences Building, University of Bristol, Bristol, BS8 1TD, UK.
Adrian J MulhollandSchool of Chemistry, University of Bristol, Bristol, BS8 1TS, UK.ORCID 0000-0003-1015-4567
At Bristol · GBUniversity of Bristol · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L01386X/1Biotechnology and Biological Sciences Research Council BB/P000940/1Medical Research Council MR/V027506/1Wellcome Trust 106115/Z/14/ZWellcome Trust 210701/Z/18/Z
6 · The paper itself

Abstract

We investigate binding of linoleate and other potential ligands to the recently discovered fatty acid binding site in the SARS-CoV-2 spike protein, using docking and molecular dynamics simulations. Simulations suggest that linoleate and dexamethasone stabilize the locked spike conformation, thus reducing the opportunity for ACE2 interaction. In contrast, cholesterol may expose the receptor-binding domain by destabilizing the closed structure, preferentially binding to a different site in the hinge region of the open structure. We docked a library of FDA-approved drugs to the fatty acid site using an approach that reproduces the structure of the linoleate complex. Docking identifies steroids (including dexamethasone and vitamin D); retinoids (some known to be active in vitro, and vitamin A); and vitamin K as potential ligands that may stabilize the closed conformation. The SARS-CoV-2 spike fatty acid site may bind a diverse array of ligands, including dietary components, and therefore provides a promising target for therapeutics or prophylaxis.

Indexed as

Molecular Dynamics SimulationBinding SitesCOVID-19Fatty AcidsHumansLigandsMolecular Docking SimulationProtein Structure, QuaternaryRetinoidsSARS-CoV-2Spike Glycoprotein, CoronavirusSteroidsVitaminsFatty AcidsLigandsRetinoidsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2SteroidsVitaminsmolecular modelingretinoidsSARS-CoV-2 spike fatty-acid-sitesteroidsvitamins

Identifiers

PMID33469977
PMCPMC8013358
OpenAlexW3099182481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.